These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1980270)

  • 21. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin.
    Miller CH; Fleischhacker WW; Ehrmann H; Kane JM
    Psychopharmacol Bull; 1990; 26(3):373-6. PubMed ID: 1980375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome.
    Walters AS; Hening W; Rubinstein M; Chokroverty S
    Sleep; 1991 Aug; 14(4):339-45. PubMed ID: 1682986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment with clonazepam for neuroleptic-induced akathisia.
    Horiguchi J; Nishimatsu O; Inami Y
    Acta Psychiatr Scand; 1989 Jul; 80(1):106-7. PubMed ID: 2569804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions.
    Braude WM; Barnes TR; Gore SM
    Br J Psychiatry; 1983 Aug; 143():139-50. PubMed ID: 6137254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotropic medications induced parkinsonism and akathisia in people attending follow-up treatment at Jimma Medical Center, Psychiatry Clinic.
    Kumsa A; Agenagnew L; Alemu B; Girma S
    PLoS One; 2020; 15(7):e0235365. PubMed ID: 32614868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Subjective experiences of patients with acute neuroleptic-induced akathisia].
    Gruber O; Northoff G; Pflug B
    Fortschr Neurol Psychiatr; 1998 Dec; 66(12):531-8. PubMed ID: 9922925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients.
    Richardson MA; Haugland G; Craig TJ
    Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A placebo-controlled trial of nadolol in the treatment of neuroleptic-induced akathisia.
    Wells BG; Cold JA; Marken PA; Brown CS; Chu CC; Johnson RP; Nasdahl CS; Ayubi MA; Knott DH; Arheart KL
    J Clin Psychiatry; 1991 Jun; 52(6):255-60. PubMed ID: 1676029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tardive Akathisia with Asymmetric and Upper-body Presentation: Report of Two Cases and Literature Review.
    Shahidi G; Rohani M; Munhoz RP; Akhoundi FH
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():563. PubMed ID: 29971200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulcal size and neuroleptic-induced akathisia.
    Sandyk R; Kay SR
    Biol Psychiatry; 1990 Feb; 27(4):466-7. PubMed ID: 1968769
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study.
    Kramer MS; Gorkin R; DiJohnson C
    Hillside J Clin Psychiatry; 1989; 11(2):107-19. PubMed ID: 2577308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restlessness of respiration as a manifestation of akathisia: five case reports of respiratory akathisia.
    Hirose S
    J Clin Psychiatry; 2000 Oct; 61(10):737-41. PubMed ID: 11078034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of propranolol, sotalol, and betaxolol in the treatment of neuroleptic-induced akathisia.
    Dupuis B; Catteau J; Dumon JP; Libert C; Petit H
    Am J Psychiatry; 1987 Jun; 144(6):802-5. PubMed ID: 2884889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Akathisia variants and tardive dyskinesia.
    Barnes TR; Braude WM
    Arch Gen Psychiatry; 1985 Sep; 42(9):874-8. PubMed ID: 2864031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum iron and transferrin in acute neuroleptic induced akathisia.
    O'Loughlin V; Dickie AC; Ebmeier KP
    J Neurol Neurosurg Psychiatry; 1991 Apr; 54(4):363-4. PubMed ID: 1676049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of efficacy of d-propranolol in neuroleptic-induced akathisia.
    Adler LA; Angrist B; Fritz P; Rotrosen J; Mallya G; Lipinski JF
    Neuropsychopharmacology; 1991 Feb; 4(2):109-15. PubMed ID: 1673844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive akathisia due to sulpiride.
    López de Munain A; Poza JJ; Gorospe A; Arce A; Martí Massó JF
    Clin Neuropharmacol; 1994 Oct; 17(5):481-3. PubMed ID: 9316700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phenomenology and therapy of neuroleptic-induced akathisia--a review of the literature].
    Seidel M
    Fortschr Neurol Psychiatr; 1989 Nov; 57(11):489-94. PubMed ID: 2574702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of ritanserin on treatment-resistant neuroleptic induced akathisia: case reports.
    Miller CH; Hummer M; Pycha R; Fleischhacker WW
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Mar; 16(2):247-51. PubMed ID: 1349760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low serum iron in patients with neuroleptic-induced akathisia and dystonia under antipsychotic drug treatment.
    Horiguchi J
    Acta Psychiatr Scand; 1991 Sep; 84(3):301-3. PubMed ID: 1683097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.